SEC Form D private-offering filing

Exin Therapeutics, Inc.

Name: Exin Therapeutics, Inc. - new SEC Form D private-offering filing, San Francisco, CA
Published: 2026-02-10

A new SEC Form D private-offering notice from San Francisco, CA, a $2,162,300 filer-stated offering target in Biotech. The source filing is one click away.

Exin Therapeutics, Inc. site↗ Verified via SEC Form D

AI-driven drug discovery platform developing genetic therapies targeting neural circuits for neurological and neuropsychiatric disorders.

Filed 2026-02-10Filed to raise $2,162,300First money in 2024-11-18Raised so far $2,162,300HQ (as filed) San Francisco, CASector Biotech ✓Stage (inferred) SeedCall status Late filing

Source linked the Form D on EDGAR↗Website verified exintherapeutics.com↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.